UPDATE 3-Halozyme's pancreatic cancer drug succeeds in mid-stage trial
Jan 5 (Reuters) - Halozyme Therapeutics Inc said its lead experimental drug, in tandem with therapies from Celgene Corp and Eli Lilly and Co, succeeded in a mid-stage study involving patients with an... [Source]
Publication Date:Origin: reuters.com
Category: hotStocksNews
Topics: mid-stage, patients, involving, study, succeeded, Lilly, from Celgene, therapies, tandem, experimental, said its, Therapeutics, Halozyme, (Reuters), trial, succeeds, cancer, pancreatic, 3-Halozyme's, UPDATE
Source: http://feeds.reuters.com/~r/reuters/hotStocksNews/~3/hNG7_0Q_NaY/halozyme-study-idUSL4N1EV3M7